Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-004832
Filing Date
2025-01-13
Accepted
2025-01-13 16:15:05
Documents
1
Period of Report
2025-01-10

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5025
  Complete submission text file 0000950170-25-004832.txt   6535
Mailing Address C/O ALEXION PHARMACUETICALS, INC. 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
Sinha Vikas (Reporting) CIK: 0001337845 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39409 | Film No.: 25526521

Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 (617) 433-2605
Allovir, Inc. (Issuer) CIK: 0001754068 (see all company filings)

EIN.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)